Sinphar Pharmaceutical Co Ltd (1734) — Cash Flow Reinvestment Rate
Sinphar Pharmaceutical Co Ltd (1734) has a Cash Flow Reinvestment Rate of 0.87x as of March 2026, reinvesting NT$101.07 Million (capex NT$101.07 Million ) from operating cash flow of NT$116.42 Million. See 1734 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sinphar Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Sinphar Pharmaceutical Co Ltd across 22 annual periods. For the full cash flow conversion analysis, see Sinphar Pharmaceutical Co Ltd cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Sinphar Pharmaceutical Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Sinphar Pharmaceutical Co Ltd. See financial flexibility index of Sinphar Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | NT$230.30 Million | NT$584.66 Million | NT$200.94 Million | ▼ -40.6% |
| 2024 | 0.66x | NT$393.33 Million | NT$593.51 Million | NT$256.71 Million | ▼ -69.1% |
| 2023 | 2.14x | NT$635.50 Million | NT$296.37 Million | NT$300.94 Million | ▲ +387.1% |
| 2022 | 0.44x | NT$187.21 Million | NT$425.30 Million | NT$153.44 Million | ▼ -63.1% |
| 2021 | 1.19x | NT$161.77 Million | NT$135.54 Million | NT$161.44 Million | ▲ +7.3% |
| 2020 | 1.11x | NT$162.79 Million | NT$146.39 Million | NT$157.77 Million | ▼ -73.5% |
| 2018 | 4.19x | NT$333.38 Million | NT$79.50 Million | NT$255.69 Million | ▲ +318.9% |
| 2017 | 1.00x | NT$220.09 Million | NT$219.87 Million | NT$171.00 Million | ▼ -63.3% |
| 2016 | 2.73x | NT$238.05 Million | NT$87.18 Million | NT$224.85 Million | ▲ +67.1% |
| 2015 | 1.63x | NT$458.26 Million | NT$280.53 Million | NT$412.04 Million | ▼ -27.5% |
| 2014 | 2.25x | NT$335.00 Million | NT$148.58 Million | NT$294.29 Million | ▼ -9.7% |
| 2013 | 2.50x | NT$741.65 Million | NT$297.09 Million | NT$598.16 Million | ▲ +9.4% |
| 2012 | 2.28x | NT$375.19 Million | NT$164.45 Million | NT$375.19 Million | ▲ +42.3% |
| 2011 | 1.60x | NT$361.69 Million | NT$225.58 Million | NT$361.69 Million | ▲ +43.2% |
| 2010 | 1.12x | NT$292.75 Million | NT$261.49 Million | NT$292.75 Million | ▲ +57.9% |
| 2009 | 0.71x | NT$219.71 Million | NT$309.94 Million | NT$219.71 Million | ▼ -17.6% |
| 2008 | 0.86x | NT$233.25 Million | NT$271.01 Million | NT$233.25 Million | ▼ -63.7% |
| 2007 | 2.37x | NT$414.90 Million | NT$174.85 Million | NT$414.90 Million | ▲ +58.5% |
| 2006 | 1.50x | NT$249.44 Million | NT$166.57 Million | NT$249.44 Million | ▼ -3.1% |
| 2005 | 1.55x | NT$188.76 Million | NT$122.09 Million | NT$188.76 Million | ▲ +68.1% |
| 2004 | 0.92x | NT$160.79 Million | NT$174.81 Million | NT$160.79 Million | ▼ -57.3% |
| 2003 | 2.16x | NT$260.50 Million | NT$120.84 Million | NT$260.50 Million | — |